T 0489/20 (Buprenorphine/LOHMANN) of 17.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T048920.20230317
- Date of decision
- 17 March 2023
- Case number
- T 0489/20
- Petition for review of
- -
- Application number
- 12826670.7
- IPC class
- A61K 9/70A61P 25/04A61K 31/485
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 116
- Application title
- TRANSDERMAL DELIVERY SYSTEM COMPRISING BUPRENORPHINE
- Applicant name
- LTS LOHMANN Therapie-Systeme AG
- Opponent name
- Luye Pharma Switzerland AG
Pajaro Limited
Hexal AG
Swindell & Pearson Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 13(2)Rules of procedure of the Boards of Appeal Art 15a(1)
- Keywords
- Amendment after summons
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of the main request, filed as auxiliary request V with the letter dated 16 February 2023, and a description to be adapted.